Estradiol Gel Packets Recalled for Empty or Partially Full Containers
ANI Pharmaceuticals is recalling Estradiol Gel 0.1% (Lot M251109) distributed nationwide because some packets were found to be either empty or partially full.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a packaging/container defect (empty or partially full packets) that poses a risk of underdosing or non-administration of a prescription medication, but no adverse health consequences have been reported.
Plain-English summary
ANI Pharmaceuticals, Inc. is recalling Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet due to defective containers. Approximately 3,964 cartons (Lot M251109, expiration November 2027) were distributed nationwide in the USA. Packets were found to be either empty or partially full.
Consumers who have received affected cartons should stop using the product and contact ANI Pharmaceuticals or their healthcare provider for guidance. Patients should not discontinue estradiol therapy without consulting their physician, as this is a prescription medication.
The recalled product
- Product
- ESTRADIOL (ESTRADIOL)
- Brand
- ESTRADIOL
- Manufacturer
- ANI Pharmaceuticals, Inc.
- Affected units
- 3,964
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot M251109
- exp Nov 2027
UPCs (5)
- 0370954531104
- 0370954530107
- 0370954532101
- 0370954534105
- 0370954533108
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ESTRADIOL
- ModerateEstradiol transdermal patches recalled for failed quality specifications
FDA (Drugs) · 2024-06-12
- ModerateEstradiol Transdermal Patch Recalled for Failed Chemical Specifications
FDA (Drugs) · 2024-06-12
- HighEstradiol 0.5mg Tablets Recalled Nationwide for Storage Temperature Deviation
FDA (Drugs) · 2024-01-03
- ModerateCardinal Health Recalls Estradiol Transdermal Systems Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateNoven Recalls Estradiol Transdermal Patches Due to Adhesive Defects
FDA (Drugs) · 2021-04-28
Same manufacturer · ANI Pharmaceuticals, Inc.
See all →- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateAlprazolam Tablets 0.5 mg Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-02-23
- ModerateAlprazolam Tablets USP 1.0 mg Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-23
- ModerateAlprazolam Tablets USP 0.25 mg Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-23
- ModeratePyrazinamide Tablets 500 mg Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-02-23
Same hazard · defective container
See all →- High
- ModeratePureLife benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateBurkhart benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModeratePearson Quality benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateDental City benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24